Grifols SA (GRFS)
9.205
-0.02
(-0.16%)
USD |
NASDAQ |
Feb 11, 16:00
9.205
0.00 (0.00%)
After-Hours: 20:00
Grifols EPS Diluted (Quarterly) : 0.2183 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Akari Therapeutics Plc | -0.1948 |
| Pharma Mar SA | -0.2749 |
| Autolus Therapeutics Plc | -0.2955 |
| Oryzon Genomics SA | 0.0052 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 167.61M |
| Revenue (Quarterly) | 2.180B |
| Total Expenses (Quarterly) | 2.032B |
| Enterprise Value | 19.71B |
| Gross Profit Margin (Quarterly) | 39.33% |
| Profit Margin (Quarterly) | 7.69% |
| Earnings Yield | 6.67% |
| Operating Earnings Yield | 24.01% |
| Normalized Earnings Yield | 6.342 |